{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:46Z","timestamp":1793459686569,"version":"4.5.0"},"reference-count":228,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A03008"],"award-info":[{"award-number":["CI2021A03008"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2021A03001"],"award-info":[{"award-number":["CI2021A03001"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e27110","type":"journal-article","created":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T18:02:10Z","timestamp":1708884130000},"page":"e27110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The recent advance and prospect of natural source compounds for the treatment of heart failure"],"prefix":"10.1016","volume":"10","author":[{"given":"Xing-Juan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Kang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Zhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Zhi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e27110_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, Part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","article-title":"Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting","volume":"159","author":"Soppert","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/ATVBAHA.120.314735","article-title":"Lymphatics in cardiovascular disease","volume":"40","author":"Zhou","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","article-title":"Gut microbiota derived metabolites in cardiovascular health and disease","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.heliyon.2024.e27110_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.heliyon.2024.e27110_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","article-title":"Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment","volume":"17","author":"Boorsma","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001699","article-title":"Heart failure care in low- and middle-income countries: systematic review and meta-analysis","volume":"11","author":"Callender","year":"2014","journal-title":"PLoS Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007132","article-title":"Risk profiles in heart failure: Baseline, residual, worsening, and advanced heart failure risk","volume":"13","author":"Greene","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/2047487320932258","article-title":"Are heart failure observational studies still useful? \u2018No need to argue\u2019","volume":"28","author":"Salzano","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ejhf.219","article-title":"Why is heart failure so important in the 21st century?","volume":"17","author":"Davison","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106035","article-title":"Current and future therapeutic perspective in chronic heart failure","volume":"175","author":"Mascolo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.119.14057","article-title":"Medical therapies for heart failure with preserved ejection faction","volume":"75","author":"Kjeldsen","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2024.e27110_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2014.05.002","article-title":"Current role of neprilysin inhibitors in hypertension and heart failure","volume":"144","author":"Lueder","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharmthera.2013.05.012","article-title":"Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction","volume":"140","author":"Konstantinou","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105573","article-title":"Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: a systematic review and network meta-analysis of randomized clinical trials","volume":"169","author":"Bao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib19","article-title":"Efficacy of three novel drugs in the treatment of heart failure: a network meta-analysis","volume":"101","author":"Luo","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib20","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/jcm10163682","article-title":"Diabetes mellitus and heart failure","volume":"10","author":"Triposkiadis","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s11883-022-01038-2","article-title":"SGLT-2 inhibitors for patients with heart failure: what have we learned recently?","volume":"24","author":"Rifai","year":"2022","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2021.12.050","article-title":"SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: a practical approach for routine clinical practice","volume":"351","author":"Giaccari","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib23","first-page":"417","article-title":"Cardiac resynchronization therapy for heart failure","volume":"6","author":"Ojo","year":"2017","journal-title":"Interv. Cardiol. Clin."},{"key":"10.1016\/j.heliyon.2024.e27110_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009634","article-title":"Role of implantable cardioverter defibrillator in heart failure with contemporary medical therapy","volume":"15","author":"Butler","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104552","article-title":"Prevention and treatment of chronic heart failure through traditional Chinese medicine: role of the gut microbiota","volume":"151","author":"Jia","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib26","first-page":"5115","article-title":"A review of Chinese herbal medicine for the treatment of chronic heart failure","volume":"23","author":"Wang","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2024.e27110_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.31083\/j.rcm2302060","article-title":"Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives","volume":"23","author":"Xu","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib28","article-title":"Traditional Chinese medicine enhances myocardial metabolism during heart failure","volume":"146","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110012","article-title":"An updated role of astragaloside IV in heart failure","volume":"126","author":"Zang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154457","article-title":"Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPAR\u03b1 in rats","volume":"107","author":"Sunagawa","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111833","article-title":"Application of omics- and multi-omics-based techniques for natural product target discovery","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib32","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1039\/D2NP00038E","article-title":"Natural product-based proteolysis targeting chimeras (PROTACs)","volume":"39","author":"Liu","year":"2022","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/med.21733","article-title":"Autophagy and cardiac diseases: therapeutic potential of natural products","volume":"41","author":"Wu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000171","article-title":"Cheminformatics in natural product-based drug discovery","volume":"39","author":"Chen","year":"2020","journal-title":"Mol. Inform."},{"key":"10.1016\/j.heliyon.2024.e27110_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-protein-coupled receptors in heart disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/mp.2016.40","article-title":"A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism","volume":"22","author":"Marques","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e27110_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-beta signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187739","article-title":"Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure","volume":"12","author":"Mora","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103992","article-title":"Inflammation and resolution signaling in cardiac repair and heart failure","volume":"79","author":"Halade","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40256-018-0280-5","article-title":"Focused treatment of heart failure with reduced ejection fraction using sacubitril\/valsartan","volume":"18","author":"Liu","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.heliyon.2024.e27110_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.36628\/ijhf.2020.0002","article-title":"Angiotensin receptor-neprilysin inhibition (ARNI) in heart failure","volume":"2","author":"Greenberg","year":"2020","journal-title":"Int. J. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2005.04.012","article-title":"Myocyte apoptosis in heart failure","volume":"67","author":"Empel","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib48","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/jcmm.16329","article-title":"Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10741-018-9708-x","article-title":"Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death\/degeneration","volume":"23","author":"Takemura","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-981-15-4272-5_16","article-title":"Autophagy and heart failure","volume":"1207","author":"Du","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature10992","article-title":"Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure","volume":"485","author":"Oka","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e27110_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib53","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e27110_bib54","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e27110_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/VHRM.S287082","article-title":"Epigenetic therapies for heart failure: current insights and future potential","volume":"17","author":"Napoli","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.heliyon.2024.e27110_bib56","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.121.054262","article-title":"HDAC inhibition in the heart: Erasing hidden fibrosis","volume":"143","author":"Gillette","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e27110_bib57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.120.318149","article-title":"Myofibroblast deficiency of LSD1 alleviates TAC-induced heart failure","volume":"129","author":"Huo","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2015.11.004","article-title":"Vascular dysfunction in heart failure with preserved ejection fraction","volume":"22","author":"Kitzman","year":"2016","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib59","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","article-title":"Coronary microvascular dysfunction in hypertrophy and heart failure","volume":"116","author":"Camici","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00228-014-1671-4","article-title":"Novel drug targets in clinical development for heart failure","volume":"70","author":"George","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110824","article-title":"Combination of LCZ696 and ACEI further improves heart failure and myocardial fibrosis after acute myocardial infarction in mice","volume":"133","author":"Liu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e27110_bib63","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.3390\/molecules26185627","article-title":"Repurposing cardiac glycosides: drugs for heart failure surmounting viruses","volume":"26","author":"Skubnik","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e27110_bib64","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00392-023-02199-z","article-title":"Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial","volume":"112","author":"Bavendiek","year":"2023","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12012-021-09702-w","article-title":"Comparative therapeutic potential of cardioactive glycosides in doxorubicin model of heart failure","volume":"22","author":"Silva Ferreira","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic resistance in heart failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib67","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2024.e27110_bib68","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11897-019-0421-4","article-title":"Vasodilator therapies in the treatment of acute heart failure","volume":"16","author":"Holt","year":"2019","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the acute heart failure committee of the heart failure association (HFA) of the European society of cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/eurheartj\/ehv755","article-title":"Agents with vasodilator properties in acute heart failure","volume":"38","author":"Singh","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e27110_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108780","article-title":"Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a\/beta-catenin and Jak2\/Stat3 pathways","volume":"113","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001294","article-title":"Beneficial and harmful effects of sacubitril\/valsartan in patients with heart failure: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis","volume":"7","author":"Nielsen","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.heliyon.2024.e27110_bib74","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.jacc.2019.09.063","article-title":"Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction","volume":"74","author":"Shah","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"10","author":"Burnett","year":"2017","journal-title":"Circ. Heart. Fail."},{"key":"10.1016\/j.heliyon.2024.e27110_bib76","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/10600280221140575","article-title":"Efficacy and safety of sacubitril\/valsartan compared with ACEI\/ARB on health-related quality of life in heart failure patients: a meta-analysis","volume":"57","author":"Yang","year":"2023","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10741-008-9094-x","article-title":"\u03b2-Blocker pharmacogenetics in heart failure","volume":"15","author":"Shin","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/VHRM.S285907","article-title":"\u03b2-Blockade for patients with hypertension, ischemic heart disease or heart failure: where are we now?","volume":"17","author":"Pathak","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.heliyon.2024.e27110_bib79","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.repc.2021.06.027","article-title":"Beta-Blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm","volume":"41","author":"Formiga","year":"2022","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib80","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e27110_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/JOE-21-0323","article-title":"Mineralocorticoid receptor antagonists, heart failure and predictive biomarkers","volume":"253","author":"Karthigan","year":"2022","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CRD.0000000000000286","article-title":"Mineralocorticoid receptor antagonist use in heart failure with reduced ejection fraction and end-stage renal disease patients on dialysis: a literature review","volume":"28","author":"Bhinder","year":"2020","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib83","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10741-019-09879-x","article-title":"Angiotensin receptor\/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings","volume":"25","author":"Ksiazczyk","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11886-018-0944-4","article-title":"The sacubitril\/valsartan, a first-in-class, angiotensin receptor neprilysin inhibitor (ARNI): potential uses in hypertension, heart failure, and beyond","volume":"20","author":"Kario","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib85","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib86","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2024.e27110_bib87","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib88","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/M21-4284","article-title":"Sodium\u2013glucose cotransporter-2 inhibitors in patients with heart failure","volume":"175","author":"Zou","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib89","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib90","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2024.e27110_bib91","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2147\/DDDT.S295214","article-title":"Evidence and current use of levosimendan in the treatment of heart failure: filling the gap","volume":"15","author":"Conti","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib93","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/jcm9051266","article-title":"Clinical evidence for Q10 coenzyme supplementation in heart failure: from energetics to functional improvement","volume":"9","author":"Di Lorenzo","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib94","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pcd.2021.04.005","article-title":"Heart failure outcomes and glucagon-like peptide-1 receptor agonists: a systematic review of observational studies","volume":"15","author":"Alkhezi","year":"2021","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.heliyon.2024.e27110_bib95","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.3390\/ijms22084180","article-title":"A comprehensive analysis into the therapeutic application of natural products as SIRT6 modulators in Alzheimer\u2019s disease, aging, cancer, inflammation, and diabetes","volume":"22","author":"Akter","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27110_bib96","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1089\/jmf.2021.0030","article-title":"Therapeutic feasibility of the natural products in the heart complaints: an overview","volume":"24","author":"Souza","year":"2021","journal-title":"J. Med. Food"},{"key":"10.1016\/j.heliyon.2024.e27110_bib97","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.21037\/apm-21-1343","article-title":"The role of flavonoids in the prevention and management of cardiovascular complications: a narrative review","volume":"10","author":"Chen","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib98","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/molecules27041320","article-title":"The role of flavonoids as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: a review","volume":"27","author":"Syahputra","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e27110_bib99","article-title":"The effects of puerarin on rat ventricular myocytes and the potential mechanism","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106152","article-title":"Role of puerarin in pathological cardiac remodeling: a review","volume":"178","author":"Lv","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112655","article-title":"Roles and mechanisms of puerarin on cardiovascular disease: a review","volume":"147","author":"Jiang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112152","article-title":"Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo\/YAP pathway","volume":"143","author":"Du","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.2042-7158.2010.01241.x","article-title":"Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure","volume":"63","author":"Song","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib104","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biopha.2016.08.016","article-title":"Icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation","volume":"83","author":"Song","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopha.2018.01.138","article-title":"Icariside II attenuates myocardial fibrosis by inhibiting nuclear factor-kappaB and the TGF-beta1\/Smad2 signalling pathway in spontaneously hypertensive rats","volume":"100","author":"Fu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib106","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2011.06.020","article-title":"Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes","volume":"668","author":"Qi","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.034","article-title":"Luteolin protects against diabetic cardiomyopathy by inhibiting NF-kappaB-mediated inflammation and activating the Nrf2-mediated antioxidant responses","volume":"59","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib108","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s10753-010-9271-7","article-title":"Luteolin prevents LPS-induced TNF-alpha expression in cardiac myocytes through inhibiting NF-kappaB signaling pathway","volume":"34","author":"Lv","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2024.e27110_bib109","article-title":"Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia\/reperfusion injury in mice","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10753-021-01530-y","article-title":"SHP-1\/STAT3 interaction is related to luteolin-induced myocardial ischemia protection","volume":"45","author":"Liu","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2024.e27110_bib111","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/14786419.2010.495070","article-title":"Protective effects of baicalin and quercetin on an iron-overloaded mouse: comparison of liver, kidney and heart tissues","volume":"25","author":"Zhang","year":"2011","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib112","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ptr.6583","article-title":"Baicalin relieves lipopolysaccharide-evoked inflammatory injury through regulation of miR-21 in H9c2 cells","volume":"34","author":"Liu","year":"2020","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib113","article-title":"Baicalin protects the cardiomyocytes from ER stress-induced apoptosis: inhibition of CHOP through induction of endothelial nitric oxide synthase","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153035","article-title":"Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury","volume":"63","author":"Bai","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1159\/000459708","article-title":"Baicalin attenuates cardiac dysfunction and myocardial remodeling in a chronic pressure-overload mice model","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e27110_bib116","article-title":"Methylophiopogonanone A protects against cerebral ischemia\/reperfusion injury and attenuates blood-brain barrier disruption in vitro","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib117","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/aps.2016.14","article-title":"Methylophiopogonanone A suppresses ischemia\/reperfusion-induced myocardial apoptosis in mice via activating PI3K\/Akt\/eNOS signaling pathway","volume":"37","author":"He","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2024.e27110_bib118","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jpba.2010.02.016","article-title":"Characterization of homoisoflavonoids in different cultivation regions of Ophiopogon japonicus and related antioxidant activity","volume":"52","author":"Lin","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e27110_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105428","article-title":"Targeting autophagy using saponins as a therapeutic and preventive strategy against human diseases","volume":"166","author":"Han","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib120","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.2147\/DDDT.S330222","article-title":"Antioxidant, anti-aging and organ protective effects of total saponins from aralia taibaiensis","volume":"15","author":"Li","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106352","article-title":"Saponins and their derivatives: potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance","volume":"182","author":"Qu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib122","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jacs.0c10836","article-title":"A SIRT1 activator, ginsenoside Rc, promotes energy metabolism in cardiomyocytes and neurons","volume":"143","author":"Huang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e27110_bib123","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.7150\/thno.43895","article-title":"Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia\/reperfusion injury through inhibiting ROS production from mitochondrial complex I","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2024.e27110_bib124","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jphp.12900","article-title":"Ginsenoside Rb1 inhibits autophagy through regulation of Rho\/ROCK and PI3K\/mTOR pathways in a pressure-overload heart failure rat model","volume":"70","author":"Yang","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000484578","article-title":"Ginsenoside Rg1 protects cardiomyocytes against hypoxia\/reoxygenation injury via activation of Nrf2\/HO-1 signaling and inhibition of JNK","volume":"44","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e27110_bib126","article-title":"Cardioprotective effects of Notoginsenoside R1 against ischemia\/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress-related signaling pathways","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109963","article-title":"MiR-30c-5p mediates the effects of panax notoginseng saponins in myocardial ischemia reperfusion injury by inhibiting oxidative stress-induced cell damage","volume":"125","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113853","article-title":"Ophiopogonin D alleviates diabetic myocardial injuries by regulating mitochondrial dynamics","volume":"271","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrc.2017.06.007","article-title":"Ophiopogonin D and EETs ameliorate Ang II-induced inflammatory responses via activating PPAR\u03b1 in HUVECs","volume":"490","author":"Huang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e27110_bib130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/jpet.114.219261","article-title":"Ophiopogonin D attenuates doxorubicin-induced autophagic cell death by relieving mitochondrial damage in vitro and in vivo","volume":"352","author":"Zhang","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e27110_bib131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/aps.2015.146","article-title":"Ophiopogonin D maintains Ca2+ homeostasis in rat cardiomyocytes in vitro by upregulating CYP2J3\/EETs and suppressing ER stress","volume":"37","author":"You","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2024.e27110_bib132","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1749-8546-4-6","article-title":"Effects of Astragaloside IV on heart failure in rats","volume":"4","author":"Zhao","year":"2009","journal-title":"Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib133","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/13880209.2020.1849319","article-title":"The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure","volume":"58","author":"Sui","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib134","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ptr.3492","article-title":"Astragalosides rescue both cardiac function and sarcoplasmic reticulum Ca2+ transport in rats with chronic heart failure","volume":"26","author":"Wang","year":"2012","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib135","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41598-017-02360-5","article-title":"Astragaloside IV alleviates heart failure via activating PPARalpha to switch glycolysis to fatty acid beta-oxidation","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib136","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13757","article-title":"Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4\/MyD88\/NF-kappaB signaling pathway","volume":"45","author":"Shi","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.heliyon.2024.e27110_bib137","first-page":"31","article-title":"An update review on the anthelmintic activity of bitter gourd, momordica charantia","volume":"11","author":"Poolperm","year":"2017","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2021.113026","article-title":"Cucurbitane-type triterpenoids from the vines of Momordica charantia and their anti-inflammatory, cytotoxic, and antidiabetic activity","volume":"195","author":"Liaw","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.heliyon.2024.e27110_bib139","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.bmc.2019.05.035","article-title":"In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L","volume":"27","author":"Shivanagoudra","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e27110_bib140","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/molecules14020738","article-title":"Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells","volume":"14","author":"Szliszka","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e27110_bib141","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ptr.5620","article-title":"Dietary phenolic acids of macrotyloma uniflorum protect the rat heart against isoproterenol-induced myocardial infarction","volume":"30","author":"Panda","year":"2016","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib142","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ptr.6573","article-title":"A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: comprehensive pharmacology, toxicology, and some pharmaceutical aspects","volume":"34","author":"Abedi","year":"2020","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114382","article-title":"Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy","volume":"160","author":"Gong","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib144","article-title":"The anti-apoptotic and cardioprotective effects of salvianolic acid a on rat cardiomyocytes following ischemia\/reperfusion by DUSP-mediated regulation of the ERK1\/2\/JNK pathway","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114438","article-title":"Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K\/AKT and PPAR signaling pathways","volume":"281","author":"Lei","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib146","article-title":"Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166560","article-title":"Salvianolic acid B alleviates heart failure by inactivating ERK1\/2\/GATA4 signaling pathway after pressure overload in mice","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib148","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8332825","article-title":"Salvianolic acid B suppresses ER stress-induced NLRP3 inflammasome and pyroptosis via the AMPK\/FoxO4 and syndecan-4\/Rac1 signaling pathways in human endothelial progenitor cells","volume":"2022","author":"Tang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib149","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.3390\/ijms23126628","article-title":"Ferulic acid, pterostilbene, and tyrosol protect the heart from ER-stress-induced injury by activating SIRT1-dependent deacetylation of eIF2\u03b1","volume":"23","author":"Monceaux","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e27110_bib150","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3754942","article-title":"Sodium ferulate protects against Angiotensin II-induced cardiac hypertrophy in mice by regulating the MAPK\/ERK and JNK pathways","volume":"2017","author":"Hu","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2024.e27110_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108735","article-title":"Sodium ferulate inhibits myocardial hypertrophy induced by abdominal coarctation in rats: involvement of cardiac PKC and MAPK signaling pathways","volume":"112","author":"Luo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib152","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.fct.2019.01.034","article-title":"Wheat phenolics suppress doxorubicin-induced cardiotoxicity via inhibition of oxidative stress, MAP kinase activation, NF-\u03baB pathway, PI3K\/Akt\/mTOR impairment, and cardiac apoptosis","volume":"125","author":"Sahu","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib153","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.phrs.2018.03.009","article-title":"Curcumin in heart failure: a choice for complementary therapy?","volume":"131","author":"Saeidinia","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib154","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways","volume":"24","author":"Ren","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib155","first-page":"7249","article-title":"Dickkopf-3 upregulation mediates the cardioprotective effects of curcumin on chronic heart failure","volume":"17","author":"Cao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153694","article-title":"Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis","volume":"91","author":"Xue","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib157","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1111\/jcmm.13552","article-title":"Nucleolin mediated pro-angiogenic role of Hydroxysafflor yellow A in ischaemic cardiac dysfunction: post-transcriptional regulation of VEGF-A and MMP-9","volume":"22","author":"Zou","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib158","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.biopha.2016.12.113","article-title":"Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I\/R) injury mainly via Akt\/hexokinase II independent of ERK\/GSK-3\u03b2 pathway","volume":"87","author":"Min","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib159","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopha.2017.10.064","article-title":"Chlorogenic acid (CGA): a pharmacological review and call for further research","volume":"97","author":"Naveed","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109755","article-title":"In vitro and in vivo studies reveal the beneficial effects of chlorogenic acid against ER stress mediated ER-phagy and associated apoptosis in the heart of diabetic rat","volume":"351","author":"Preetha Rani","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2024.e27110_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116479","article-title":"Chlorogenic acid, rutin, and quercetin from Lysimachia christinae alleviate triptolide-induced multi-organ injury in vivo by modulating immunity and AKT\/mTOR signal pathway to inhibit ferroptosis and apoptosis","volume":"467","author":"Wu","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib162","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.phytochem.2012.05.012","article-title":"Fifty years of alkaloid biosynthesis in Phytochemistry","volume":"91","author":"Cordell","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.heliyon.2024.e27110_bib163","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3390\/molecules26113374","article-title":"Diversity in chemical structures and biological properties of plant alkaloids","volume":"26","author":"Bhambhani","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e27110_bib164","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/bph.15000","article-title":"Tetramethylpyrazine: a promising drug for the treatment of pulmonary hypertension","volume":"177","author":"Chen","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib165","doi-asserted-by":"crossref","first-page":"15098","DOI":"10.1002\/jcp.28151","article-title":"Retracted: tetramethylpyrazine partially relieves hypoxia-caused damage of cardiomyocytes H9c2 by downregulation of miR-449a","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib166","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000374076","article-title":"Tetramethylpyrazine ameliorated hypoxia-induced myocardial cell apoptosis via HIF-1\u03b1\/JNK\/p38 and IGFBP3\/BNIP3 inhibition to upregulate PI3K\/Akt survival signaling","volume":"36","author":"Lin","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e27110_bib167","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/aps.2014.75","article-title":"Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure","volume":"35","author":"Li","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2024.e27110_bib168","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13020-020-00345-7","article-title":"The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism","volume":"15","author":"Chen","year":"2020","journal-title":"Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib169","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/molecules27041351","article-title":"Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease","volume":"27","author":"Och","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e27110_bib170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ptr.6217","article-title":"Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-\u03baB and AMPK signaling pathways","volume":"33","author":"Pei","year":"2019","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib171","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10495-015-1122-4","article-title":"Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1\/Hes1-PTEN\/Akt signaling","volume":"20","author":"Yu","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.heliyon.2024.e27110_bib172","first-page":"230","article-title":"Berberine protects myocardial cells against anoxia-reoxygenation injury via p38 MAPK-mediated NF-\u03baB signaling pathways","volume":"17","author":"Zhao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib173","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jep.2016.12.033","article-title":"Applications of Higenamine in pharmacology and medicine","volume":"196","author":"Zhang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib174","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1111\/jcmm.15041","article-title":"Therapeutic effects of higenamine combined with [6]-gingerol on chronic heart failure induced by doxorubicin via ameliorating mitochondrial function","volume":"24","author":"Wen","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib175","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/med.21777","article-title":"Cardiac efficacy and toxicity of aconitine: a new frontier for the ancient poison","volume":"41","author":"Zhou","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.heliyon.2024.e27110_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113765","article-title":"Aconitine attenuates mitochondrial dysfunction of cardiomyocytes via promoting deacetylation of cyclophilin-D mediated by sirtuin-3","volume":"270","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib177","first-page":"284","article-title":"Aconitine induces apoptosis in H9c2 cardiac cells via mitochondria-mediated pathway","volume":"17","author":"Gao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113115","article-title":"An insight into current advances on pharmacology, pharmacokinetics, toxicity and detoxification of aconitine","volume":"151","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib179","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/clc.23691","article-title":"The safety of morphine in patients with acute heart failure: a systematic review and meta-analysis","volume":"44","author":"Zhang","year":"2021","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2005.08.025","article-title":"Alterations in protein kinase A and different protein kinase C isoforms in the heart during morphine withdrawal","volume":"522","author":"Cerezo","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib181","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/bjp.2008.224","article-title":"The PKs PKA and ERK 1\/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts","volume":"155","author":"Almela","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib182","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.carbpol.2014.06.010","article-title":"Polysaccharide-based strategies for heart tissue engineering","volume":"116","author":"Silva","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.heliyon.2024.e27110_bib183","article-title":"Antioxidant effect of polygonatum sibiricum polysaccharides in D-galactose-induced heart aging mice","volume":"2021","author":"Ma","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2024.e27110_bib184","first-page":"1","article-title":"Astragalus polysaccharide alleviates LPS-induced inflammation injury by regulating miR-127 in H9c2 cardiomyoblasts","volume":"32","author":"Ren","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.etap.2015.03.014","article-title":"Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-\u03b1\/PGC-1alpha signaling mediated energy biosynthesis","volume":"39","author":"Luan","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib186","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.etap.2014.05.008","article-title":"Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca2+-mediated calcineurin\/NFATc3 and CaMKII signaling cascades","volume":"38","author":"Dai","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib187","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s11033-012-2325-1","article-title":"Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARalpha mice","volume":"40","author":"Chen","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28414-w","article-title":"Identification of genes underlying the enhancement of immunity by a formula of lentinan, pachymaran and tremelia polysaccharides in immunosuppressive mice","volume":"8","author":"Luo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105490","article-title":"Carboxymethyl pachymaran attenuates short-term stress induced depressive behaviours and over-expression of occludin and claudin-2 in the blood\u2013brain-barrier by regulating inflammatory cytokines-JNK\/ERK\/p38 pathway","volume":"103","author":"He","year":"2023","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.heliyon.2024.e27110_bib190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jep.2012.02.048","article-title":"Effect of poria cocos on hypertonic stress-induced water channel expression and apoptosis in renal collecting duct cells","volume":"141","author":"Lee","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib191","article-title":"Effect of Poria cocos on ouromycin aminonucleoside-induced nephrotic syndrome in rats","volume":"2014","author":"Lee","year":"2014","journal-title":"J. Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib192","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jep.2016.01.037","article-title":"Ophiopogon japonicus--A phytochemical, ethnomedicinal and pharmacological review","volume":"181","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib193","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijbiomac.2020.01.068","article-title":"Cardioprotective effect of the polysaccharide from Ophiopogon japonicus on isoproterenol-induced myocardial ischemia in rats","volume":"147","author":"Fan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib194","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijbiomac.2015.09.069","article-title":"Cardiovascular protective effect of polysaccharide from Ophiopogon japonicus in diabetic rats","volume":"82","author":"Zhang","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib195","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/DDDT.S367469","article-title":"Lycium barbarum polysaccharide prevents cisplatin induced MLTC-1 cell apoptosis and autophagy via regulating endoplasmic reticulum stress pathway","volume":"16","author":"Yang","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib196","article-title":"Activation of the Nrf2\/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage","volume":"9","author":"He","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib197","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1111\/jcmm.13740","article-title":"Lycium barbarum polysaccharides restore adverse structural remodelling and cardiac contractile dysfunction induced by overexpression of microRNA-1","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib198","article-title":"Application quantitative proteomics approach to identify differentially expressed proteins associated with cardiac protection mediated by cycloastragenol in acute myocardial infarction rats","volume":"222","author":"Ren","year":"2020","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.heliyon.2024.e27110_bib199","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.phymed.2017.12.003","article-title":"Astragaloside VI and cycloastragenol-6-O-beta-D-glucoside promote wound healing in vitro and in vivo","volume":"38","author":"Lee","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib200","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.biopha.2018.08.016","article-title":"Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling","volume":"107","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib201","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11596-021-2414-2","article-title":"Pachymic acid ameliorates pulmonary hypertension by regulating Nrf2-Keap1-ARE pathway","volume":"42","author":"He","year":"2022","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e27110_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114278","article-title":"Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis","volume":"278","author":"Bi","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.15586\/aei.v49i5.468","article-title":"Pachymic acid inhibits inflammation and cell apoptosis in lipopolysaccharide (LPS)-induced rat model with pneumonia by regulating NF-\u03baB and MAPK pathways","volume":"49","author":"Gui","year":"2021","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib204","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3892\/mmr.2015.3712","article-title":"Pachymic acid protects H9c2 cardiomyocytes from lipopolysaccharide-induced inflammation and apoptosis by inhibiting the extracellular signal-regulated kinase 1\/2 and p38 pathways","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib205","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.2147\/DDDT.S266911","article-title":"Pharmacological activity and mechanism of tanshinone IIA in related diseases","volume":"14","author":"Guo","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib206","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1142\/S0192415X22500914","article-title":"Tanshinone IIA regulates Keap1\/Nrf2 signal pathway by activating sestrin2 to restrain pulmonary fibrosis","volume":"50","author":"Li","year":"2022","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib207","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092216","article-title":"The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108599","article-title":"Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs\/mTOR-dependent autophagy pathway","volume":"112","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e27110_bib209","article-title":"Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e27110_bib210","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202590","article-title":"Schisandrin B attenuates diabetic cardiomyopathy by targeting MyD88 and inhibiting MyD88-dependent inflammation","volume":"9","author":"Luo","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.heliyon.2024.e27110_bib211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000510863","article-title":"Schisandrin B protects against acute ethanol-induced cardiac injury by downregulating autophagy via the NOX4\/ROS pathway","volume":"106","author":"Tao","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.heliyon.2024.e27110_bib212","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms","volume":"69","author":"Hao","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106515","article-title":"Hypertensive heart disease and myocardial fibrosis: how traditional Chinese medicine can help addressing unmet therapeutical needs","volume":"185","author":"Liu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e27110_bib214","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3892\/etm.2015.2759","article-title":"Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction","volume":"10","author":"Xiao","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib215","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jacc.2013.05.035","article-title":"Safety of Qili Qiangxin Capsules for chronic heart failure study, a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure","volume":"62","author":"Li","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib216","article-title":"Qishen Yiqi Dropping Pill facilitates post-stroke recovery of motion and memory loss by modulating ICAM-1-mediated neuroinflammation, Biomed","volume":"153","author":"Liu","year":"2022","journal-title":"Pharmacother"},{"key":"10.1016\/j.heliyon.2024.e27110_bib217","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jep.2015.11.023","article-title":"Qishenyiqi Dropping Pill attenuates myocardial fibrosis in rats by inhibiting RAAS-mediated arachidonic acid inflammation","volume":"176","author":"Wang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154336","article-title":"Shexiang Baoxin Pill attenuates myocardial ischemia\/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway","volume":"104","author":"Yu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115279","article-title":"Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction","volume":"293","author":"Song","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib220","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3892\/etm.2021.9985","article-title":"Effects of Shenfu Qiangxin Drink on H2O2-induced oxidative stress, inflammation and apoptosis in neonatal rat cardiomyocytes and possible underlying mechanisms","volume":"21","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e27110_bib221","article-title":"A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)","volume":"99","author":"Guo","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib222","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jep.2016.08.031","article-title":"Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy","volume":"192","author":"Li","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e27110_bib223","article-title":"Mechanisms of Chinese medicine Xinmailong\u2019s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes","volume":"7","author":"Qi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e27110_bib224","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014960","article-title":"Yixinshu capsule combined with conventional treatment for chronic heart failure: protocol for a systematic review and trial sequential analysis","volume":"98","author":"Cai","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154185","article-title":"Yi-Xin-Shu capsule ameliorates cardiac hypertrophy by regulating RB\/HDAC1\/GATA4 signaling pathway based on proteomic and mass spectrometry image analysis","volume":"103","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e27110_bib226","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.2147\/DDDT.S112333","article-title":"Systematic review and meta-analysis of randomized controlled trials on Wenxin keli","volume":"10","author":"Wang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2024.e27110_bib227","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/molecules27113647","article-title":"Systematic qualitative and quantitative analyses of Wenxin Granule via ultra-high performance liquid chromatography coupled with ion mobility quadrupole time-of-flight mass spectrometry and triple quadrupole-linear ion trap mass spectrometry","volume":"27","author":"Mi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e27110_bib228","article-title":"Efficacy and safety of oral Chinese patent medicine combined with conventional therapy for heart failure: an overview of systematic reviews","volume":"2020","author":"Lin","year":"2020","journal-title":"J. Evid. Based Complement. Alternat. Med."}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2025.e43897","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024031414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024031414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:54:11Z","timestamp":1769046851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024031414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":228,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024031414"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27110","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The recent advance and prospect of natural source compounds for the treatment of heart failure","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e27110"}}